Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 2
2003 1
2004 4
2005 5
2006 4
2007 1
2008 3
2009 7
2010 12
2011 16
2012 8
2013 5
2014 8
2015 10
2016 10
2017 7
2018 3
2019 6
2020 5
2021 9
2022 4
2023 4
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

114 results

Results by year

Filters applied: . Clear all
Page 1
Immunogenicity of three versus four doses of 13-valent pneumococcal conjugate vaccine followed by 23-valent pneumococcal polysaccharide vaccine in allogeneic haematopoietic stem cell transplantation recipients: a multicentre, randomized controlled trial.
Okinaka K, Akeda Y, Inamoto Y, Fuji S, Ito A, Tanaka T, Kurosawa S, Kim SW, Tanosaki R, Yamashita T, Ohwada C, Kurata K, Mori T, Onozawa M, Takano K, Yokoyama H, Koh K, Nagafuji K, Nakayama K, Sakura T, Takahashi T, Oishi K, Fukuda T. Okinaka K, et al. Among authors: yamashita t. Clin Microbiol Infect. 2023 Apr;29(4):482-489. doi: 10.1016/j.cmi.2022.12.007. Epub 2022 Dec 8. Clin Microbiol Infect. 2023. PMID: 36503114 Clinical Trial.
Case report of nivolumab-related pneumonitis.
Tada K, Kurihara Y, Myojo T, Kojima F, Ishikawa Y, Yoshiyasu N, Morimoto M, Ito R, Koyamada R, Yamashita T, Bando T, Mori S, Heike Y. Tada K, et al. Among authors: yamashita t. Immunotherapy. 2017 Mar;9(4):313-318. doi: 10.2217/imt-2016-0129. Immunotherapy. 2017. PMID: 28303763
Carbon Nanomaterials: Efficacy and Safety for Nanomedicine.
Yamashita T, Yamashita K, Nabeshi H, Yoshikawa T, Yoshioka Y, Tsunoda SI, Tsutsumi Y. Yamashita T, et al. Materials (Basel). 2012 Feb 21;5(2):350-363. doi: 10.3390/ma5020350. Materials (Basel). 2012. PMID: 28817050 Free PMC article. Review.
N-3 fatty acids modulate repeated stress-evoked pain chronicity.
Aizawa F, Sato S, Yamazaki F, Yao I, Yamashita T, Nakamoto K, Kasuya F, Setou M, Tokuyama S. Aizawa F, et al. Among authors: yamashita t. Brain Res. 2019 Jul 1;1714:218-226. doi: 10.1016/j.brainres.2019.03.001. Epub 2019 Mar 2. Brain Res. 2019. PMID: 30831087
Efficacy and Safety of 4-Weekly Docetaxel for Castration-Resistant Prostate Cancer.
Yamashita T, Shiota M, Machidori A, Kobayashi S, Matsumoto T, Monji K, Kashiwagi E, Takeuchi A, Takahashi R, Inokuchi J, Shiga KI, Yokomizo A, Eto M. Yamashita T, et al. Cancer Invest. 2021 Mar;39(3):251-256. doi: 10.1080/07357907.2020.1871486. Epub 2021 Jan 14. Cancer Invest. 2021. PMID: 33393849 Clinical Trial.
Dysfunctional GPR40/FFAR1 signaling exacerbates pain behavior in mice.
Nakamoto K, Aizawa F, Miyagi K, Yamashita T, Mankura M, Koyama Y, Kasuya F, Hirasawa A, Kurihara T, Miyata A, Tokuyama S. Nakamoto K, et al. Among authors: yamashita t. PLoS One. 2017 Jul 19;12(7):e0180610. doi: 10.1371/journal.pone.0180610. eCollection 2017. PLoS One. 2017. PMID: 28723961 Free PMC article.
Feasibility and usefulness of recommended screenings at long-term follow-up clinics for hematopoietic cell transplant survivors.
Kurosawa S, Yamaguchi T, Mori A, Tsukagoshi M, Okuda I, Ikeda M, Ueno T, Saito Y, Aihara Y, Matsuba Y, Fuji S, Yamashita T, Ogawa C, Ito A, Tanaka T, Inamoto Y, Kim SW, Fukuda T. Kurosawa S, et al. Among authors: yamashita t. Support Care Cancer. 2022 Mar;30(3):2767-2776. doi: 10.1007/s00520-021-06698-5. Epub 2021 Nov 27. Support Care Cancer. 2022. PMID: 34837539
114 results